Biliverdin improved angiogenesis and suppressed apoptosis via PI3K/Akt-mediated Nrf2 antioxidant system to promote ischemic flap survival.

MLA

Yao, Zhe, et al. “Biliverdin Improved Angiogenesis and Suppressed Apoptosis via PI3K/Akt-Mediated Nrf2 Antioxidant System to Promote Ischemic Flap Survival.” Free Radical Biology & Medicine, vol. 225, Nov. 2024, pp. 35–52. EBSCOhost, https://doi.org/10.1016/j.freeradbiomed.2024.09.042.

APA

Yao, Z., Xue, K., Chen, J., Zhang, Y., Zhang, G., Zheng, Z., Li, Z., Li, Z., Wang, F., Sun, X., Shen, L., Mao, C., & Lin, C. (2024). Biliverdin improved angiogenesis and suppressed apoptosis via PI3K/Akt-mediated Nrf2 antioxidant system to promote ischemic flap survival. Free Radical Biology & Medicine, 225, 35–52. https://doi.org/10.1016/j.freeradbiomed.2024.09.042

Chicago

Yao, Zhe, Kaikai Xue, Jinghao Chen, Yu Zhang, Guojian Zhang, Zimin Zheng, Zihao Li, et al. 2024. “Biliverdin Improved Angiogenesis and Suppressed Apoptosis via PI3K/Akt-Mediated Nrf2 Antioxidant System to Promote Ischemic Flap Survival.” Free Radical Biology & Medicine 225 (November): 35–52. doi:10.1016/j.freeradbiomed.2024.09.042.